Trial Profile

A clinical trial assessing safety and tolerability study of BR01T for Chronic Low Back Pain (CLBP)

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 20 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BR 01T (Primary)
Indications Back pain
Focus Adverse reactions

Most Recent Events

20 Oct 2023 New trial record
18 Oct 2023 According to Brise Pharmaceuticals media release, first participant dosed in this trial, The trial is set to be conducted at a prestigious JBR CenExel clinical research center located in Salt Lake City, Utah, USA.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com